Eris Lifesciences Ltd (NSE:ERIS)
₹ 1042.9 11.1 (1.08%) Market Cap: 141.66 Bil Enterprise Value: 155.44 Bil PE Ratio: 36.17 PB Ratio: 5.48 GF Score: 97/100

Q3 2022 Eris Lifesciences Ltd Earnings Call Transcript

Jan 28, 2022 / 10:30AM GMT
Release Date Price: ₹696.2 (-2.04%)
Operator

Ladies and gentlemen, good day, and welcome to the Q3 and 9M FY '22 Conference Call of Eris Lifesciences.

We have with us on the call today, Mr. Amit Bakshi, Chairman and Managing Director; and Mr. V. Krishnakumar, Chief Operating Officer and Executive Director. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. V Krishnakumar, Chief Operating Officer and Executive Director of the company. Thank you, and over to you, sir.

Krishnakumar Vaidyanathan
Eris Lifesciences Limited - Executive Director & COO

Thank you. Good afternoon, and welcome to our third quarter conference call. I'm Krishnakumar, and I'm happy to share the highlights of the quarter with you.

As per the AIOCD retail audit, the Indian pharma market grew at 5.7% in quarter 3 of this year on the back of a 6.4% growth in quarter 3 of last year. In comparison, I'm happy to share that Eris grew at 7.8% in quarter 3 of this year on the back of a 14.5% growth in quarter 3 of last year. If you look at the first 9

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot